Sorrento Therapeutics Inc (SRNE)

[dia76ca]

The entire biotech sector has been pounded. What Sorrento needs are one or two approvals! I expect at least two this month.
* EUA granted for Covi-Stix
* EUA granted for Covi-Track
* These approvals will be followed by worldwide sales partnerships.
* We should also hear from the interim analysis of the Abivirtinib phase 2 trial to prevent cytokine storm. Will this also receive an EUA? If so we should also expect approvals and sales around the world beginning in the US, Mexico and Brazil.
* I also expect good results will be announced from the open label phase 1 Covi-MSC trial of 20 patients with ARDS. And a pivotal phase 2 trial will begin.

And there should be more good news from the cancer and pain portfolios in the next month or two. The great science will prevail!